Extracting Value from Potential Discards: The Importance of Sequencing Tumor Remnants for Clinical Research
Tracy Curley, MAcc
Bulk-sequencing specimen remnants helps advance the development of next-gen diagnostics and personalized treatments
Tracy Curley, MAcc
Tracy Curley, MAcc, is CEO of iSpecimen, an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers.